Moreover, since there is no Ki67 record in SEER database, we divided breast cancer molecular types according to HR and HER2 status as follows: HR+HER2+, HR-HER2+, HR+HER2-, HR-HER2-. This evidence concerns the gene MKI67 and breast carcinoma.